Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
ICER Report Takes Aim at Seven Prescription Drug Price Increases
In December 2021, the Institute for Clinical and Economic Review (ICER) released a new report on Unsupported Price Increases (UPI)…
House Oversight Publishes Competing Views of Drug Pricing Investigation
Highlighting the partisan nature of Congress these days, the House Oversight and Reform Committee and the Republicans on the…
Biden Administration Rescinds Trump Administration Insulin Pricing Rule
One of the final healthcare actions made by the Trump Administration has been rescinded by the Biden Administration. On December…
Three Generic Pharmaceutical Manufacturers Agree to $447 Million Settlement…
On October 1, 2021, the United States Department of Justice announced that three generic pharmaceutical manufacturers agreed to…
CBO Simulates the Elijah E. Cummings Lower Drug Costs Now Act
The Congressional Budget Office (CBO) recently released a Simulation Model of New Drug Development that mimicked the Elijah E.…
Alternative Drug Pricing Legislation Introduced by Moderate Democrats
Centrist Democrats in the United States House of Representatives are working on introducing an alternate approach to drug pricing…
Biden Administration Announces Drug Pricing Plan
On September 9, 2021, the United States Department of Health and Human Services (HHS) issued its Comprehensive Plan for Addressing…
Arkansas Prohibits Manufacturers from Offering Discounts on Insulin…
On May 3, 2021, Arkansas Governor Asa Hutchinson signed HB1709 into law, which prohibits manufacturers from offering discounts on…
Wyden Releases Principles for Lowering Prescription Drug Prices
On June 22, 2021, Senate Finance Committee Chairman Ron Wyden released principles lowering prescription drug prices. In the…
House of Representatives Holds Hearing Focused on AbbVie Business Practices
On May 18, 2021, the United States House of Representatives Committee on Oversight and Reform held a hearing in which it reviewed…